Thursday, 10 May 2018

Jubilant Life stock rises after Q4FY18 PAT gains

The company's consolidated revenue in Q4FY18 rose 40.9% to Rs2,252cr vs Rs1,598cr in Q4FY17. Jubilant Life Sciences Ltd is currently trading at Rs857.05 up by Rs10.3 or 1.22% from its previous closing of Rs846.75 on the BSE. PAT grew by 2.3% yoy to Rs152.4cr. The PAT came lower as company had booked one‐time charges, adjusted for which PAT growth is higher at 63.3% yoy to Rs243cr in Q4FY18.

To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = 
Visit =

No comments:

Post a Comment